Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.76
-0.15 (-2.17%)
At close: Jun 18, 2026, 4:00 PM EDT
6.70
-0.06 (-0.89%)
After-hours: Jun 18, 2026, 4:10 PM EDT
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$218,794
Profits / Employee
$4,812,206
Market Cap
27.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -191 | -84.89% |
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Vistagen Therapeutics | 59 |
| Evaxion | 46 |
| Senti Biosciences Holdings | 39 |
| Longeveron | 38 |
| Plus Therapeutics | 28 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
KYNB News
- 7 days ago - Kyntra Bio Transcript: AGM 2026 - Transcripts
- 8 days ago - Kyntra Bio to present additional MATTERHORN trial data at EHA - TheFly
- 8 days ago - Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes - GlobeNewsWire
- 11 days ago - Kyntra Bio initiated with a Buy at Rodman & Renshaw - TheFly
- 5 weeks ago - Kyntra Bio Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Kyntra Bio Earnings release: Q1 2026 - Filings
- 5 weeks ago - Kyntra Bio Slides: Q1 2026 - Filings
- 5 weeks ago - Kyntra Bio Quarterly report: Q1 2026 - Filings